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Abstract
Mature microRNAs (miRNAs) are single-stranded RNAs of 18–24 nucleotides that repress post-transcriptional gene
expression. However, it is unknown whether the functions of mature miRNAs can be regulated. Here we report that
expression of versican 39UTR induces organ adhesion in transgenic mice by modulating miR-199a* activities. The study was
initiated by the hypothesis that the non-coding 39UTR plays a role in the regulation of miRNA function. Transgenic mice
expressing a construct harboring the 39UTR of versican exhibits the adhesion of organs. Computational analysis indicated
that a large number of microRNAs could bind to this fragment potentially including miR-199a*. Expression of versican and
fibronectin, two targets of miR-199a*, are up-regulated in transgenic mice, suggesting that the 39UTR binds and modulates
miR-199a* activities, freeing mRNAs of versican and fibronectin from being repressed by miR-199a*. Confirmation of the
binding was performed by PCR using mature miR-199a* as a primer and the targeting was performed by luciferase assays.
Enhanced adhesion by expression of the 39UTR was confirmed by in vitro assays. Our results demonstrated that upon arrival
in cytoplasm, miRNA activities can be modulated locally by the 39UTR. Our assay may be developed as sophisticated
approaches for studying the mutual regulation of miRNAs and mRNAs in vitro and in vivo. We anticipate that expression of
the 39UTR may be an approach in the development of gene therapy.
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Introduction
Human Genome Project identified approximately 25,000
protein-coding genes, occupying 1.9% of total genomic DNA.
The remaining DNA has come to be known as ‘‘junk’’ DNA or
cellular detritus and was presumed to serve no particular function
because it does not code proteins. Pseudogenes are part of these
non-functional DNAs since they are the defective copies of the
protein-coding genes. In fact, pseudogenes are nearly as abundant
astheprotein-codinggenesandthereforeappearto beanimportant
component of the genome. It has been reported that there are
approximately 20,000 putative pseudogenes in the human genome
[1,2]. A large number of pseudogenes are found to be transcribed.
Analysis of chromosome 22 indicated that approximately 20% of
the pseudogenes are potentially transcribed [3]. Pseudogene
transcription has also been reported in other species including fly,
mouse, cow, and chimp [4]. The assumption that pseudogenes are
dysfunctional is based on the fact that pseudogenes do not code for
proteins. However, it is unknown whether non-coding RNAs can
affect microRNAs (miRNAs) functions.
miRNAs are single-stranded RNA of 18–24 nucleotides in length
and are generated by an RNase III-type enzyme from an endogenous
transcript thatcontainsalocalhairpinstructure [5,6]. miRNAfunctions
as a guide molecule in post-transcriptional gene silencing by partially
complementing with the 39-untranslated region (39UTR) of the target
mRNAs, leading to translational repression [7–9]. By silencing various
target mRNAs, miRNAs have key roles in diverse regulatory pathways,
including controlling development [10–15], cell differentiation [16–20],
apoptosis [21,22], cell proliferation [23–25], division [26,27], protein
secretion [28,29], immuno-response [30], viral infection [31–34], and
cancer development [35–47]. Functionally, miRNAs are opposite to
transcription factors, which turn on genes, while miRNAs function as
modulators by down-regulating gene expression [7,48]. Studies
associated with miRNA functions and regulations of gene expression
by mature miRNAs are overwhelming. However, it is unknown
whether the mature miRNAs can also be regulated. We hypothesize
that the mRNA 39UTRs can bind to and regulate miRNA functions.
In this study, we used versican 39UTR as a model to study the role of
the non-coding transcript. Versican is an extracellular proteoglycan that
has been shown to mediated varieties of cell activities [49–53]. We
found that the expression of the versican 39UTR induced cell, tissue,
and organ adhesion by arresting miR-199a* functions.
Results and Discussion
Transgenic expression of versican 39UTR induces organ
adhesion
To study the effect of versican 39UTR on modulating miRNA
functions, we cloned and placed the 39UTR under the control of
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(Fig 1a). The fragment containing the transcription unit was
cropped for the generation of transgenic mice and we obtained
four versican 39UTR transgenic founder animals. All were bred
with wildtype mice and we obtained a total of twelve litters of F1
mice. Genotyping was performed by PCR using two different pairs
of primers and the result from one litter is shown in Fig 1b.
Expression of the transgene in a number of organs was confirmed
by RT-PCR (Fig 1c). Real-time PCR analysis indicated that the
levels of the 39UTR were 45-fold higher than that of wild-type
(Fig 1d). A number of the positive F1 and wild-type mice were
sacrificed and examined. We observed that in some 39UTR mice,
Figure 1. Organ adhesion detected in transgenic mice expressing versican 39UTR. (a), A fragment of versican 39UTR (700 bp) immediately
after the stop codon containing a small fragment at the 39 of versican coding sequence was inserted into the pcDNA3.1 plasmid, downstream of the
CMV promoter, between XbaI and ApaI sites, producing Ver-UTR construct. Total RNA was prepared from one pooled cell line and two individual
clones stably transfected with Ver39UTR or the empty vector, subjected to RT-PCR, and analyzed on agarose gel electrophoresis. Expression of the
39UTR was confirmed. (b) Genotyping PCR was performed on tail DNA extracted from the same litter of F1 using two pairs of primers amplifying the
promoter region (CMV) and the downstream transcript versican 39UTR. (c) Expression of the transgene was analyzed by RT-PCR using RNAs isolated
from different organs of 39UTR transgenic mice. (d) The levels of versican 39UTR were analyzed by real-time PCR in Hek293 cells transfected with the
39UTR construct or a control vector (detecting endogenous versican). The levels of 39UTR in the 39UTR-transfected cells were over 45-fold that of the
control. (e) Photograph showing adhesion of the liver to the stomach. (f) Photograph showing organ adhesion occurred between liver and
diaphragm. One piece of liver was adhered to the diaphragm. (g) A liver was adhered to the internal body walls of the mouse. (h) Paraffin sections of
the adhesion tissues were stained with hematoxylin and eosin (H&E). Both photographs show the linking between the livers and connective tissues.
doi:10.1371/journal.pone.0004527.g001
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others, the livers adhered with connective tissues sticking to the
internal body wall (Fig 1f, arrows) or directly adhered to it (Fig 1g).
In a different transgenic line, stomach adhesion (Fig S1b) and liver
adhesion (Fig S1c) were also observed. These adhering organs
were subjected to histological analysis by hematoxylin and eosin
(H&E) staining. Adhesion of livers with connective tissues could be
clearly seen (Fig 1h, arrows).
Expression of versican 39UTR induces cell adhesion
To study how versican 39UTR affected organ adhesion, we
examined its effects on cell lines stably expressing the 39UTR.
Human astrocytoma cell line U343 was stably transfected with the
39UTR construct or an empty vector. The cells were cultured in
DMEM containing 10% FBS at a cell density of 5610
4 cells/ml
and examined under a light microscope and photographed. The
39UTR-transfected cells attached to tissue culture plates slower
than the vector-transfected cells (Fig S1d). After cell attachment,
the UTR-transfected cells tended to adhere together and appeared
less elongated (Fig 2a). Two days after cell inoculation, large
groups of the 39UTR-transfected cells could be detected, forming
an island-like morphology (Fig 2b).
To confirm the direct effect of the 39UTR, 4 different siRNAs
complementary to the 39UTR were synthesized. Down regulation
of the 39UTR was confirmed by real-time PCR amplifying a
fragment of the 39UTR (Fig 2c, left). Cell adhesion assays showed
that transfection with the siRNAs partially rescued the reduced
adhesion in the 39UTR-transfected cells (Fig 2c, right). Further-
more, transfection of the siRNA also reversed the altered cell
morphology (Fig 2d).
We developed a number of experiments to analyze the effects of
the 39UTR. It was linked with the construct expressing versican
Figure 2. Cell adhesion and morphology affected by versican 39UTR. Vector- or 39UTR-transfected cells were inoculated in tissue culture
dishes overnight. Cell morphology was examined under a light microscope (a). Two days after cell inoculation, the 39UTR-expressing cells exhibiting
island-like morphology (b). The 39UTR-transfected cells were transiently transfected with siRNA targeting the 39UTR or a control sequence, followed
by real-time PCR analysis of the 39UTR levels (c, left). Cell adhesion of the two groups of cells was compared with the vector-transfected cells. Down-
regulation of the 39UTR levels increased cell adhesion (c, right). Typical results of cell adhesion are shown (d, left). Cell morphology was also
examined. Down-regulation of the 39UTR levels reversed the morphology (d, right). Luciferase reporter vector harboring the versican 39UTR was co-
transfected with the versican 39UTR construct at different amount combined with a control vector in U343 cells. Increase rations of versican 39UTR
bound more endogenous miR199a* and thus freeing the translation of luciferase protein, resulting in higher levels of luciferase activities (e).
doi:10.1371/journal.pone.0004527.g002
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prepared from U343 cells stably transfected with the G3 and G3-
UTR constructs and were subjected to Western blot analysis
probed with anti-G3 and anti-actin antibodies simultaneously.
While actin levels were similar, G3 levels were much lower in cells
transfected with the G3-UTR construct (Fig S2a). This result
suggests that some endogenous miRNAs targeted the 39UTR and
repressed G3 expression.
The 39UTR was also linked with the GFP expression unit (Fig
S2b, upper). Fluorescent levels of U87 and U343 cells stably
transfected with the GFP and GFP-UTR constructs were
measured with flow cytometry. Cells transfected with the GFP-
UTR construct produced lower levels of fluorescence than that
transfected with the GFP construct (Fig S2b, middle and lower).
Cells transfected with the GFP and GFP-UTR constructs were
also examined under a light and fluorescent microscope.
Transfection with the GFP-UTR construct produced lower levels
of GFP than the controls (Fig S2c).
Furthermore, the 39UTR was linked to the luciferase report
vector producing the lu-VUTR construct. Cells that were
transfected with different concentrations of lu-VUTR always
produced lower levels of luciferase activity than cells transfected
with a control construct (Fig S3a), suggesting repression of
luciferase expression by endogenous miRNAs. Nevertheless, with
increased concentrations of lu-VUTR, the relative luciferase
activities increased when normalized with the control construct.
This suggests that higher concentrations of lu-VUTR would
absorb some endogenous miRNAs and free more lu-VUTR to be
expressed. To confirm this, the lu-VUTR construct was co-
transfected with the 39UTR construct. Increased 39UTR concen-
trations generated higher levels of luciferase activities in U343 cells
(Fig 2e) and U87 cells (Fig S3b). These results suggest that versican
39UTR plays a key role in the induction of adhesion.
Versican 39UTR interacts with miRNS-199a*
To test the direct interaction of miRNAs with the 39UTR, we
developed a PCR assay to test the potential binding interactions of
the miRNAs with the 39UTR and to validate the target sites in
silico. This method assumes that the miRNAs targeting the 39UTR
could serve as a PCR-primer, and the PCR products could be
generated by a 59UTR-specific primer pairing with the miRNA
primer. The nucleotide sequence of miRNA-X primer corre-
sponds to the RNA sequence of miRNA-X but with the
substitution of uridine for thymidine (Supporting Fig S1a). The
versican 39UTR construct was used as a PCR-template (Fig 3a).
We analyzed the potential miRNAs that bind to the 39UTR of
the Ver-UTR construct. A number of candidates with low binding
energy were detected. We tested 17 different miRNAs selected
from the potential candidates for the 39UTR of versican. As shown
in Fig 3b and Supporting Fig S3c, PCR products with expected
sizes were generated by using two different annealing tempera-
tures. There was no correlation between positive PCR results and
the G/C content or the melting temperature of primers, which
indicated the specificity of miRNAs toward the 39UTR of
versican. This method can be used to screen miRNAs that bind
to the 39UTR of interest. It is more efficient than the commonly-
used luciferase assay and can be used to confirm the candidate
binding sites as identified by other tools. Nevertheless, this is not to
replace any existing methods. Rather, it adds an alternative
approach to identify miRNAs targeting a 39UTR of interest. It
also produces a shorter list of candidates for validation by
luciferase activity assays and transfection experiments.
It is expected that one 39UTR contains many miRNA binding
sites and one miRNA might target many 39UTRs. This would
create a balanced network composing of the synergy and
counteraction of miRNA-39UTR interactions. The homeostatsis
of miRNAs and miRNA-binding sites might be disrupted through
changes in the expression of transcripts or miRNAs. Over-
expression of the versican 39UTR would affect the levels of free
miRNAs through binding the miRNAs, which normally regulate
versican expression by targeting its 39UTRs. The formation of
miRNA-39UTR transcript duplex thus decreases the functional
miRNA levels. This interaction would affect protein expression,
leading to the functional consequences.
Using the computation algorithm FindTar (http://bio.sz.
tsinghua.edu.cn/findtar), we found a great number of miRNAs
potentially targeting the versican 39UTR. One of the positive
miRNAs that showed interaction with the versican 39UTR is miR-
199a*. Using the online search engine TargetScan4.0 (www.
targetscan.org), we found a great number of genes that are
potentially targets of miR-199a* including versican (Genbank
access number NM_004385) and fibronectin variant 1-6 (Genbank
access number NM_212482, NM_212475, NM_002026,
NM_212478, NM_212476, and NM_212474). Fibronectin is an
extracellular glycoprotein which binds to integrins and mediates
cell adhesion, proliferation, tissue development, and life mainte-
nance [55,56]. It helps maintain cell shape by lining up cells and
organizing their intracellular cytoskeleton. Our previous studies
indicated that versican regulates cell proliferation, adhesion,
aggregation, blood coagulation, and angiogenesis [57–62]. Thus,
we hypothesized that the overexpression of versican 39UTR would
attract endogenous miR-199a*, freeing versican and fibronectin
mRNA for translation. Increased versican expression would
produce the consequences observed in this study.
Transgenic expression of versican 39UTR increases levels
of endogenous versican
To test whether the expression of versican 39UTR affected
versican expression, we prepared protein lysates from the brain,
heart, kidneys, lungs, and spleen and analyzed versican expression
by western blotting. Our experiments showed that the 39UTR
transgenic mice expressed higher levels of versican compared with
the wild-type mice (Fig 4a). The organs were also subjected to
histological analysis probed with anti-versican antibody. In the
reproductive system, versican levels were much higher in the
39UTR mice as compared with the wild-type mice (Fig 4b,
arrows). As well, versican levels were much higher in the airways
and pulmonary blood vessels of the 39UTR lung (Fig 4c, arrows),
in the livers (Fig 4d), the connective tissues (Fig 4e), and the ribs of
the 39UTR mice compared with the wild-type organs (Fig 4f). In
the adhering organs of livers and pancreas, versican expression in
the 39UTR pancreas was much higher compared with the wild-
type (Fig 4g). Normally, the liver does not adhere to any organ.
However, in the 39UTR mice, the liver adhered tightly to others
such as pancreases and connective tissues of the body wall (Fig 4h).
In the extreme case, the liver lost its smooth edges (Fig 4h, middle)
and even merged with the connective tissue (Fig 4h, bottom).
Increased versican expression was also detected in the junction
areas of stomach and connective tissues (Fig S3d). The adhesion
tissues were also immunostained for type I collagen expression, as
type I collagen is an important adhesion molecule [63,64]. We
found that the junction of adhesion tissues expressed high levels of
type I collagen (Fig S3e). This result indicated that type I collagen
plays a role in versican 39UTR-induced organ adhesion.
To confirm if versican was a target of miR-199a*, U343 cells
were co-transfected with versican 39UTR-luciferase construct (lu-
VUTR) or the mutant lu-Ver-mut, in which the miR-199a* target
site was mutated by nucleotide replacement (Fig 4i, upper).
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versican 39UTR reduced luciferase activities, mutation of the miR-
199a* target site partially rescued luciferase activities (Fig 4i,
lower). This suggests that miR-199a* repressed versican expression
by targeting the 39UTR. Furthermore, incomplete rescue of
luciferase activities suggests that the versican 39UTR is also
targeted by other endogenous miRNAs.
Transgenic expression of versican 39UTR promotes
fibronectin expression
To test whether the expression of versican 39UTR affected
fibronectin levels, we prepared protein lysates from the brain,
heart, kidneys, lungs, and spleen and analyzed fibronectin
expression by western blotting. Our experiments showed that
the 39UTR transgenic mice expressed higher levels of fibronectin
compared with the wild-type mice (Fig 5a). The organs were also
subjected to histological analysis probed with anti-fibronectin
antibody. In the spleen, fibronectin levels were higher in the
connective tissue structures of the 39UTR mice as compared with
the wild-type mice (Fig 5b, arrows). As well, fibronectin levels were
higher in the brain (Fig 5c, arrows), connective tissues (Fig 5d),
liver (Fig 5e), and ribs (Fig 5f) of the 39UTR mice compared with
the wild-type organs. In the adhering organs of livers and
pancreas, fibronectin expression in the 39UTR pancreas was
clearly detected (Fig 5g, upper). In the adhesion organs associated
with liver and connective tissue, fibronectin was strongly expressed
in the connective tissues adhering to the liver (Fig 5g, middle and
lower). In the extreme cases, where the liver lost its smooth edges
and mixed up with the connective tissue, fibronectin translation
was greatly promoted (Fig 5h). Furthermore, fibronectin levels
were much higher in the adhesion areas between liver/liver, liver/
stomach, liver/muscle, and pancreas/stomach (Fig 5i).
To confirm that fibronectin was a target of miR-199a*, we
cloned the fragment of fibronectin 39UTR containing the miR-
199a* target site. The fragment was inserted into the luciferase
reporter vector producing a construct lu-FNUTR. The potential
target site of miR-199a* was mutated producing lu-FNmut. U343
cells were co-transfected with fibronectin 39UTR-luciferase
construct (lu-FNUTR) or the mutant lu-FNmut (Fig 5j, upper).
Luciferase activity assays showed that insertion of the fibronectin
Figure 3. Targeting of versican 39UTR with miRNAs. (a) Scheme for PCR method to test the interaction of miRNAs with versican 39UTR. An
oligonucleotide corresponding to miRNA-X is used as a reverse primer. It binds to the potential targeting sites on the antisense strand of the 39UTR
construct, depending on the extent of complementation. One forward primer docked on a different location of the vector was used to pair with the
miRNA primer for PCR. (b) PCR products were obtained showing different size of products corresponding to the forward primer and the miRNA
sequences. The expected sizes of PCR products are indicated with arrows. The miRNA sequences used were listed in Supporting Fig S1a. (c)
Computational analysis showed that miR-199a* potentially targeted both versican and fibronectin 39UTRs. Overexpression of versican 39UTR would
attract endogenous miR-199a* freeing versican mRNA and fibronectin mRNA for translation.
doi:10.1371/journal.pone.0004527.g003
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(Fig 5j, lower). Mutation of the miR-199a* target site partially
rescued luciferase activities. This suggests that miR-199a*
repressed fibronectin expression by targeting the 39UTR of
fibronectin. Incomplete rescue of luciferase activities suggests that
the fibronectin 39UTR is also targeted by other endogenous
miRNAs. When lu-FNUTR was co-expressed with Ver-UTR,
luciferase activities increased (Fig S4f), suggesting a competition of
miRNAs between Ver-UTR and lu-FNUTR.
Our experiments indicated that the functions of miRNAs can be
regulated by a fragment of non-coding transcript. Genomic
deletion/truncation leading to translational silencing produces
mutant phenotypes as the consequence of protein loss/mutation
accompanied by the existence of non-coding/mutation transcripts.
Figure 4. Up-regulation of versican expression in transgenic mice expressing versican 39UTR. (a) Protein lysates were prepared from
different organs and subjected to western blot analysis probed with anti-versican antibody. Detection of b-actin on the same membranes served as a
loading control. Increased versican expression was detected in the organs harvested from the transgenic mice. (b–f) Paraffin sections of tissues from
reproductive system (b), lung (c), liver (d), connective tissues (e), and rib (f) of the 39UTR-transgenic and wild-type mice were stained with anti-
versican antibody. In all sections shown, versican expression levels in the transgenic mice were higher as compared with the wild-type (arrows). (g)
The levels of versican expression were higher in the pancreas that adhered to the liver (arrows). (h) The levels of versican expression were higher in
the junctions between liver and the surrounding connective tissues (arrows). In the lower panel identified by the circle, some liver tissues (solid arrow)
and connective tissues (open arrow), stained with anti-versican antibody, were mixed up, and no border could be identified between the different
tissues. (i) Versican 39UTR (nucleotides 275–299 of the 39UTR, Upper) was found to be the potential target of miR-199a*. A versican 39UTR was cloned
and inserted into the luciferase reporter vector pMir-Report. Mutations were generated on the potential target sequence (red color). Lower, U343
cells were co-transfected with the miR-199a construct and the luciferase reporter construct harboring the versican 39UTR (lu-VUTR) or the mutant
construct (lu-Ver-mut). As a negative control, the luciferase reporter construct was engineered with a non-related fragment of cDNA (Ctrl). Luciferase
activity assays indicated that the miR-199a construct repressed luciferase activities when it harbored the versican 39UTR, which was abolished when
the potential miR-199a* target site was mutated. Significant differences are indicated by asterisks. ** Error bars, SEM (n=3), ** p,0.01.
doi:10.1371/journal.pone.0004527.g004
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interest in studying gene functions. After gene knock-out, the
protein is no longer expressed, but it is conceivable that the
mutated genes are still able to produce non-coding transcripts.
Sometimes, no detectable phenotypes are obtained, and it is said
that the mutated/lost proteins may be compensated with others.
Although compensation by other proteins is possible, the non-
coding transcript may play an important role in compensation and
balancing the mutant entity. Our results demonstrate a dramatic
functional consequence by expressing a non-coding transcript.
Exogenous expression of the 39UTR construct altered the
expression of some proteins functionally associated with the
39UTR. It is possible that the 39UTR can play more diverse roles
than the protein expressed by the same transcript, although
proteins are the executants of biological activities. Therefore, while
analyzing the results of gene knock-out, one may need to consider
Figure 5. Up-regulation of fibronectin expression in transgenic mice expressing versican 39UTR. (a) Protein lysates were prepared from
different organs and subjected to western blot analysis probed with anti-fibronectin antibody. Detection of b-actin on the same membranes served
as a loading control. Increased fibronectin expression was detected in the organs harvested from the transgenic mice. (b–f) Paraffin sections of tissues
from spleen (b), brain (c), connective tissue (d), liver (e), and rib (f) of the 39UTR-transgenic and wild-type mice were stained with anti-fibronectin
antibody. In the transgenic spleen, the connective tissue structures expressed higher levels of fibronectin than the wild-type tissues did (arrows). In
the transgenic brain, fibronectin expression was higher in the blood vessels (arrows). In the connective tissues of the transgenic mice, some areas
expressed higher levels of fibronectin as compared with the wild-type (arrows). In the transgenic liver, fibronectin expression was higher along the
edges of the liver than the wild-type liver. (g) The levels of fibronectin expression were higher in the 39UTR pancreas that adhered to the liver
(arrows). The connective tissues that adhered to the livers also expressed high levels of fibronectin. (h) In a different mouse, the 39UTR connective
tissues, while expressed high levels of fibronectin, were strongly adhered with the liver. Pulling out the connective tissue severely damaged the liver
surface (upper panel, arrow). In the areas identified by the circles, some liver tissues (solid arrow) and connective tissues (open arrow, stained with
anti-fibronectin antibody) were completely merged. (i) Adhesion of different organs was detected between liver/liver, liver/muscle, liver/stomach, and
pancreas/stomach. The junctions between the organs expressed high levels of fibronectin (arrows). (j) Fibronectin 39UTR (nucleotides 663–683 of the
39UTR, Upper) was found to be the potential target of miR-199a*. A fibronectin 39UTR was cloned and inserted into the luciferase reporter vector
pMir-Report. Mutations were generated on the potential target sequence (pink color). Lower, U343 cells were co-transfected with the miR-199a
construct and the luciferase reporter construct harboring the fibronectin 39UTR (lu-FNUTR) or the mutant construct (lu-FNmut). Luciferase activity
assays indicated that the miR-199a construct repressed luciferase activities when it harbored the fibronectin 39UTR, which was abolished when the
potential miR-199a* target site was mutated. Significant differences are indicated by asterisks. ** Error bars, SEM (n=3), ** p,0.01.
doi:10.1371/journal.pone.0004527.g005
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coding transcripts. Our results that exogenous expression of the
versican 39UTR promoted versican expression suggest that each
mRNA may exert at east two functional roles: through protein
translation and miRNA regulation.
The human genome contains a large number of pseudogenes,
which are nearly as abundant as the functional genes and therefore
appear to be an important component in the genome. It has been
reported that there are approximately 20,000 putative pseudo-
genes in the human genome [2]. A large number of pseudogenes
are found to be transcribed. Analysis of chromosome 22 indicated
that approximately 20% of the pseudogenes are potentially
transcribed [3]. Pseudogene transcription has also been reported
in other species including fly, mouse, cow, and chimpanzee [4].
The assumption that pseudogenes are dysfunctional is based on
the fact that pseudogenes do not code for proteins. It is possible
that these non-coding transcripts of the pseudogenes play
important roles as modulators in miRNA functions.
It seemed that expression of the 39UTR produced a similar
functional role as the miRNA inhibitor. However, one 39UTR has
the capacity to modulate multiple miRNAs, while one miRNA
inhibitor can only affect one miRNA. In this sense, a 39UTR may
be able to exert diverse biological activities by modulating multiple
miRNA functions. As such, an animal gene, with long sequence of
the 39UTR, may have the capacity of exerting complex biological
activities. Furthermore, a long fragment of 39UTR may be more
stable, while the miRNA inhibitor may be readily degraded. Thus,
expression of a 39UTR may have great advantage in modulating
cell activities. In terms of stability and functionality, the 39UTR
may be better than normal mRNA, in that a mRNA has many
tasks to carry out, while a 39UTR may only exist for miRNA
binding. In the former case, binding with multiple factors involved
in protein synthesis and formation of secondary structures would
decrease the accessibility for miRNAs. In the latter case, a simple
39UTR fragment would be much more accessible for miRNA
binding. This may explain why expression of a non-coding
fragment could serve as a vigorous tool and produce potent effects
in vitro and in vivo. Furthermore, the 39UTR may free a group of
miRNAs that modulate mRNAs with related biological functions.
Changes in miRNA regulation may improve translation of the
network of related proteins, providing immediate, effective, and
lasting biological effects. One could imagine that the future
applications will be benefited by the application of the 39UTR
transcript in gene therapy.
Materials and Methods
Construct generation
To study the effect of versican 39UTR on cell activities, we have
cloned the 39UTR by RT-PCR using two primers Huver-
UTRNXbaI and Huver-UTRCApaI. The PCR product was
digested with restriction enzymes XbaI and ApaI and inserted into
XbaI- and ApaI-opened pcDNA3.1 vector. After transformation,
colony selection, DNA mini-preparation, and restriction enzyme
digestion, the correct clones were sequenced to ensure identity of
the 39UTR.
A luciferase reporter vector (pMir-Report; Ambion) was used to
generate the luciferase constructs. The 39UTR of versican was
cloned using 2 primers, HuverUTR-NSpeI and HuverUTR-
CHindIII, by PCR. The PCR products were then digested with
SpeI and HindIII and the fragment was inserted into a SpeI- and
HindIII-digested pMir-Report Luciferase plasmid (Ambion), to
obtain a luciferase construct, lu-VUTR. Primers used in this study
are listed in the Supporting Fig S1a. A mutant construct was
generated with two PCRs, one using two primers, HuverUTR-
NSpeI and HuverUTR-mu-RXbaI, the other using HuverUTR-
mu-FXbaI and HuverUTR-CHindIII. After restriction enzyme
digestion, one with SpeI and XbaI, and the other with XbaI and
HindIII, both fragments were ligated with pMir-Report vector
opened with SpeI and HindIII.
A fragment of the 39UTR of fibronectin was also cloned using 2
primers, FN1-N39SacI and FN-199aC39MluI, by RT-PCR. The
PCR products were then digested with SacI and MluI and the
fragment was inserted into a SacI- and MluI- digested pMir-Report
Luciferase plasmid (Ambion), to obtain a luciferase construct, lu-
FNUTR. A mutant construct was generated with two primers FN1-
N39SacI and FN-199aC39MluI-Mut using similar approach.
To serve as a negative control, a non-related sequence was
amplified from the coding sequence of the chicken versican G3
domain using 2 primers, chver10051SpeI and chver10350SacI. It
is expected that there is no endogenous miRNA bind to this
fragment as it is in the coding region. The PCR product was then
inserted into a SpeI- and SacI-digested pMir-Report Luciferase
plasmid.
PCR identification for miRNA-UTR interaction
For in vitro binding of microRNAs with versican 39UTR, a PCR
method was developed. The pcDNA3.1 plasmid containing the
39UTR of versican was used as the template in PCR. The forward
primer located at the vector (pcDNA3.1hygro). The reverse
primers for different miRNAs are listed in Supporting Fig S1a. In
general, the PCR mixture (20 ml) contained: 100 mM KCl,
100 mM (NH4)2SO4, 200 mM Tris HCl, pH 8.75, 1.0% Triton
X-100, 1 mg/ml BSA, 200 mM dNTPs, 2 mM forward primer,
2 mM reverse primer, 1 unit Taq DNA polymerase. The
parameters for the PCR reaction were: one cycle at 95uC for
5 min; 35 cycles at 95uC for 1 min, 37uC for 1 min, 72uC for
1 min; and a final elongation step at 72uC for 10 min. The PCR
products were then visualized with a 1.5% agarose gel stained with
ethidium bromide.
Generation and genotyping of the 39UTR transgenic mice
The transgene was released from the plasmid by digestion with
ApaLI and StuI. The digested product was fractionated by agarose
gel electrophoresis and the 3 kb transgene fragment was excised
from the gel, purified by Elutip mini-column (Schleicher and
Schuell, Keene, NH) and then resuspended in injection buffer
(10 mM Tris, pH 8.0 and 0.1 mM EDTA) at a concentration of 1
to 2 ng/ml. The transgene was microinjected into the male
pronuclei of C57BL/66CBA F2 mouse zygotes. Injected embryos
were implanted into the oviducts of pseudopregnant recipient
females using a standard protocol approved by the Animal Use
Subcommittee of the University Council on Animal Care, The
University of Western Ontario. Transgenic founder lines were
maintained by backcrossing with C57BL/66CBA F1 mice.
Genotyping was performed by PCR, using primers EGFP-347F
pairing with EGFP-668R (for CMV promoter and huver10861F
pairing with Huversican-UTRCApaI (for versican 39UTR), and
tail snip or ear punch DNA as template. GAPDH served as a
control using primers mo-Gapdh1F and mo-Gapdh250R. The
transgenic mice were then transferred to Sunnybrook Research
Institute (Toronto, Ontario). The methods for tissue harvest and
analysis have been approved by the Animal Care Committee of
Sunnybrook Research Institute, Ontario, Canada.
Cell adhesion assay
Vector- or 39UTR-transfected cells were plated onto culture
dishes at a density of 4610
5 cells/ml and incubated for 30 min
Function of 39UTR
PLoS ONE | www.plosone.org 8 February 2009 | Volume 4 | Issue 2 | e4527with DMEM containing 5% FBS. After 30 min, cells were fixed
with 3.7% paraformaldehyde. Adhering cells were counted and
cell images were captured using a phase-contrast microscope. Ten
different fields (1006) were used for cell counting.
Western blot
Organs were weighted and homogenized with lysis buffer
containing protease inhibitors (150 mM NaCl, 25 mM Tris-HCl,
pH 8.0, 0.5 M EDTA, 20% Triton X-100, 8 M Urea, and 16
protease inhibitor cocktail). Protein concentration was measured
by Bio-Rad Protein Assay kit (#5000-0006). The lysates were
subjected to SDS-PAGE and then transferred to nitrocellulose
membranes probed with a primary antibody against versican
(Lifespan Biosciences, LS-C25140), fibronectin (BD, 610078), or
b-actin (Sigma-Aldrich) overnight at 4uC. After incubation with
corresponding HRP-conjugated secondary antibodies, the mem-
branes were washed, followed by detection with the ECL kit.
Tissue slide preparation and immunohistochemistry
Organs were freshly excised and fixed in formalin overnight,
immersed in 70% ethanol, embedded in paraffin, and sectioned by a
microtome (Leica RM2255). The sections were de-paraffinized with
xylene and ethanol and then boiled in a pressure cooker. After
washing with Tris-Buffered-Saline (TBS) containing 0.025% Triton
X-100, the sections were blocked with 10% goat serum and incubated
with primary antibody against versican, fibronectin, or collagen Ia1
(Santa Cruz, sc-25974) in TBS containing 1% bovine serum albumin
(BSA) overnight. The sections were washed and labeled with
biotinylated secondary antibody, followed by avidin conjugated
horse-radish peroxidase provided by the Vectastain ABC kit (Vector,
PK-4000). The staining was developed by DAB kit (Vector, SK-
4100). The slides were subsequently stained with Mayer’s Hematox-
ylin for counter staining followed by slide mounting.
Luciferase assay
U343 cells were seeded onto 24-well tissue culture plates at a
density of 3610
4 cells/well in DMEM containing 10% FBS and
maintained at 37uC for 24 hrs following the methods described by
us recently [65,66]. The cells were co-transfected with the luciferase
reporter constructs and the 39UTR construct by using Lipofecta-
mine 2000. The cells were then collected by trypsin and lysed with a
luciferase specific lysis buffer from Luciferase Assay Kit (Promega).
Cells were centrifuged at 3000 rpm for 5 min. The supernatants
were transferred into a black 96-well plate (3610 ml) for luciferase
activity measurement and into a transparent 96-well plate (3650 ml)
for b-gal activity determination. For the luciferase activity
measurement, 70 ml of luciferase assay reagent was added into each
well and the luciferase activity was detected by using microplate
scintillation and luminescence counter (Packard, Perkin Elmer). For
the internal control of b-gal activities, 90 ml of assay reagent (4 mg/
ml ONPG, 0.5 M MgSO4, b-mercaptoethanol and 0.4 M sodium
phosphate buffer) were added into each well. The plate was then
incubated at 37uC for 60 min. The absorbance at 410 nm was
measured by using a microplate reader (Bio-Tek Instruments, Inc.).
Statistical Analysis
The results (mean values6SD) of all the experiments were
subjected to statistical analysis by t-test. The level of significance
was set at p,0.05.
Supporting Information
Figure S1 (a) Primers used in this study. (b–c) Photographs
showing organ adhesion occurred between liver and stomach (b),
between liver and body (c) in a different transgenic line of mice. (d)
Vector- or the 39UTR-transfected cells were inoculated in tissue
culture dishes for 2.5 hours. Cell adhesion was examined under a
light microscope and photographed.
Found at: doi:10.1371/journal.pone.0004527.s001 (8.01 MB TIF)
Figure S2 a, Upper, to test the effect of the versican 39UTR, the
versican G3 domain was linked with or without the 39UTR
producing G3 and G3-UTR constructs. Lower, cell lysates
prepared from U343 cells stably transfected with the G3 and
G3-UTR constructs were subjected to Western blot analysis
probed with anti-G3 and anti-actin antibodies simultaneously.
While actin levels were similar, G3 levels were much lower in cells
transfected with the G3-UTR construct. Fig S2b, the GFP coding
sequence was linked with or without the 39UTR producing GFP
and GFP-UTR constructs (Upper). Cells transfected with the
GFP-UTR construct produced lower levels of GFP activities than
that transfected with the GFP construct. The levels of fluorescent
cells were quantified (Middle). Typical fluorescent levels of U87
and U343 cells transiently transfected with the GFP and GFP-
UTR constructs were shown (Lower). Fig S2c, Cells transfected
with the GFP and GFP-UTR constructs were also examined
under a light and fluorescent microscope. Typical results are
shown.
Found at: doi:10.1371/journal.pone.0004527.s002 (8.51 MB TIF)
Figure S3 (a) U343 cells were transiently transfected with
luciferase reporter vector harboring the versican 39UTR (lu-
VUTR) or a control sequence (ctrl). Luciferase activities were
normalized using the control as 100%. The luciferase activities of
lu-VUTR never reached the levels of the control, suggesting
endogenous miRNAs targeting the versican 39UTR. Nevertheless,
the activities increased with higher does of plasmids, suggesting
that increased supplies of versican 39UTR absorbed some
endogenous miRNAs freeing luciferase translation. (b) Luciferase
reporter vector harboring the versican 39UTR was co-transfected
with the versican 39UTR construct at different amount combined
with a control vector in U87 cells. Increase amounts of versican
39UTR bound more endogenous miR199a* and freeing the
translation of luciferase protein, resulting in higher levels of
luciferase activities. (c) PCR was performed using one forward
primer docked on the vector and one of the mature miRNAs as
indicated at a different temperature (35uC). PCR products were
obtained showing different sizes of products corresponding to the
forward primer and the miRNA sequences. (d) Photographs
showing organ adhesion occurred between stomach and connec-
tive tissues. The sections were immunostained with anti-versican
antibody showing that versican was deposited in the adhesion
junction areas. (e) The adhesion tissues were sectioned and
immunostainined with anti-type I collagen that normally deposits
in wound healing areas. Collagen was expressed at high levels in
the areas of tissue adhesion.
Found at: doi:10.1371/journal.pone.0004527.s003 (9.01 MB TIF)
Figure S4 Paraffin sections of adhesion organs from a different
transgenic line of mice were stained with anti-fibronectin antibody.
The levels of fibronectin expression were higher in the adhesion
junctions between liver and pancreas (a), between liver and
connective tissue (b–e), and between liver and liver (e, right).
Luciferase reporter vector harboring the fibronectin 39UTR was
co-transfected with the versican 39UTR construct at different
amount combined with a control vector in U343 cells. Increased
ratios of versican 39UTR bound more endogenous miR199a* and
thus freeing the translation of luciferase protein, resulting in higher
levels of luciferase activities (f).
Found at: doi:10.1371/journal.pone.0004527.s004 (9.31 MB TIF)
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